BackAimei Health Technology Co Ltd - Tradeable Rights - Nov 2028 Overview

Aimei Health Technology Co Ltd - Tradeable Rights - Nov 2028 Current Cash

Track Aimei Health Technology Co Ltd - Tradeable Rights - Nov 2028's current cash ($19K) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Current Cash
$18516.00
152.09% YoYΔ $11171.00 vs prior year quarter

Peer average

Loading

Aimei Health Technology Co Ltd - Tradeable Rights - Nov 2028 Current Cash History

Loading

Aimei Health Technology Co Ltd - Tradeable Rights - Nov 2028 vs. peers: Current Cash Comparison

Loading

Aimei Health Technology Co Ltd - Tradeable Rights - Nov 2028 Cash Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Aimei Health Technology Co Ltd - Tradeable Rights - Nov 2028 (AFJKR) FAQ

The latest current cash for AFJKR is $19K as of March 2026. That compares with $7.3K in the prior-year period — up 152.1% year over year. Investors often review this figure alongside Aimei Health Technology Co Ltd - Tradeable Rights - Nov 2028's historical trend and sector peers before judging valuation or financial health.

Over the past year, AFJKR's current cash moved from $7.3K to $19K — a 152.1% year-over-year increase. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Aimei Health Technology Co Ltd - Tradeable Rights - Nov 2028's operating scale or balance-sheet position.

A current cash figure of $19K for AFJKR is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. Explore the charts below for those layers of context.

After noting AFJKR's current cash ($19K), review year-over-year change from $7.3K, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.